Peripheral arterial disease and cardiovascular risk in Italy. Results of the Peripheral Arteriopathy and Cardiovascular Events (PACE) study

Objective Our knowledge about the natural history of peripheral arterial disease (PAD) is derived from studies carried out almost exclusively in northern European and northern American populations. This study was aimed at defining mortality and cardiovascular morbidity of PAD patients in Italy. Methods From the lists of seven general practitioners, we identified all subjects aged 40–80 years (n = 4352). Of those reporting leg symptoms while walking at the Rose Questionnaire (n = 760), 60 (1.6% of the general population) had PAD, as evidenced by an ankle–brachial index of < 0.90 or reduced Doppler flow velocity. For each PAD patient, three sex and age-matched controls negative to the Rose Questionnaire were randomly selected from the general practice lists. Results After 24 months of follow-up, 15% of PAD patients died, 8% from cardiovascular disease, and 25% developed a non-fatal cardiovascular event. At Cox analysis, the presence of PAD was associated with an increased risk of all-cause mortality (relative risk 4.03; 95% confidence interval 1.50–10.84; P = 0.006), cardiovascular mortality (relative risk 7.77; 95% confidence interval 1.51–40.16; P = 0.014), and non-fatal cardiovascular events (relative risk 3.11; 95% confidence interval 1.41–6.80; P = 0.005). Conclusions This Italian study shows that, in general practice, symptomatic PAD is associated with a four-fold increased risk of mortality and a nearly eight-fold increased risk of cardiovascular mortality. These figures are quite similar to those reported in northern European and northern American populations. General practitioners, who are the clinicians primarily and largely responsible for the care of these patients, should be alerted to the consequences of PAD.

[1]  P. Greenland,et al.  Atherosclerotic Risk Factors Are Less Intensively Treated in Patients with Peripheral Arterial Disease Than in Patients with Coronary Artery Disease , 1997, Journal of General Internal Medicine.

[2]  J. Allenberg,et al.  Excess 1-year cardiovascular risk in elderly primary care patients with a low ankle-brachial index (ABI) and high homocysteine level. , 2005, Atherosclerosis.

[3]  R. Eberhardt,et al.  Cardiovascular morbidity and mortality in peripheral arterial disease. , 2004, Current drug targets. Cardiovascular & haematological disorders.

[4]  M. Chiariello,et al.  Prevalence, risk factors and cardiovascular comorbidity of symptomatic peripheral arterial disease in Italy. , 2004, Atherosclerosis.

[5]  O. Wagner,et al.  Statin therapy improves cardiovascular outcome of patients with peripheral artery disease. , 2004, European heart journal.

[6]  A. Mattioli,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[7]  Catherine Sudlow,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[8]  J. Hamming,et al.  Quality of life in patients with intermittent claudication using the World Health Organisation (WHO) questionnaire. , 2001, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[9]  M. Criqui,et al.  Peripheral arterial disease detection, awareness, and treatment in primary care. , 2001, JAMA.

[10]  D Kromhout,et al.  Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart , 2000, Heart.

[11]  J. Dormandy,et al.  The natural history of claudication: risk to life and limb. , 1999, Seminars in vascular surgery.

[12]  N. Powe,et al.  Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[13]  Arno W. Hoes,et al.  Peripheral arterial disease in the elderly: The Rotterdam Study. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[14]  R B D'Agostino,et al.  Intermittent claudication. A risk profile from The Framingham Heart Study. , 1997, Circulation.

[15]  Janet B. Dunbar,et al.  Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. , 1996, International journal of epidemiology.

[16]  C. Sabbà,et al.  Quality of Life in Patients with Intermittent Claudication: Relationship with Laboratory Exercise Performance , 1996, Vascular medicine.

[17]  R. Hamman,et al.  Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. , 1995, Circulation.

[18]  L. Kuller,et al.  The relationship between ankle brachial index, other atherosclerotic disease, diabetes, smoking and mortality in older men and women. , 1993, Atherosclerosis.

[19]  R. Langer,et al.  Mortality over a period of 10 years in patients with peripheral arterial disease. , 1992, The New England journal of medicine.

[20]  D. O’Riordain,et al.  Realistic expectations for the patient with intermittent claudication , 1991, The British journal of surgery.

[21]  R. Prescott,et al.  Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. , 1991, International journal of epidemiology.

[22]  A. Keys,et al.  Seven countries. A multivariate analysis of death and coronary heart disease. , 1980 .

[23]  E. Bernstein,et al.  Quantitative Ultrasonographic Studies of Lower Extremity Flow Velocities in Health and Disease , 1976, Circulation.

[24]  D.,et al.  Regression Models and Life-Tables , 2022 .